Billions of dollars are pouring into research aimed at rejuvenating cells to a younger state, as scientists explore ways to combat the aging process. But how close are we really to these experimental treatments becoming reality?

The conversation is heating up: a recent roundtable discussion with Mary Beth Griggs and Jessica Hamzelou delves into this emerging field of longevity science.

While the promise of reprogramming cells sounds like something from a sci-fi novel, the potential benefits could be revolutionary. From treating age-related diseases to potentially extending human lifespan, the implications are profound. However, many questions remain: will these treatments work as intended? And at what cost?

The conversation raises ethical and practical concerns too. As the technology advances, it’s essential to consider its long-term impacts on society.

Stay tuned for more insights from MIT Technology Review, where cutting-edge research meets real-world application.